Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286299193> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4286299193 endingPage "2021" @default.
- W4286299193 startingPage "2021" @default.
- W4286299193 abstract "2021 Background: Accurate diagnosis and prognostication of intra-axial brain tumors hinges on invasive brain sampling, which carries risk of morbidity. Minimally invasive sampling of proximal fluids, also known as liquid biopsy, can mitigate this risk. Although the cerebrospinal fluid (CSF) is the ideal liquid biopsy source, the traditionally high volumes required for impactful analyses have deterred progress. The objective of this study was to identify diagnostic and prognostic CSF proteomic signatures in glioblastoma (GBM), brain metastases (BM), and central nervous system lymphoma (CNSL). Methods: CSF samples were retrospectively retrieved from the Penn State Neuroscience Biorepository and profiled using shotgun proteomics with ultra-low sample volumes. Proteomic signatures were identified using machine learning classifiers and survival analyses. Results: Using 30µL CSF volumes, we recovered 800 unique peptides across 73 samples [20 normal pressure hydrocephalus (NPH, non-tumor control), 22 GBM, 17 BM, and 14 CNSL]. Externally-validated proteomic-based classifiers identified malignancy with AUROC of 0.94 and distinguished individual tumor entities from others with AUROC ≥0.96. More clinically relevant triplex classifiers, comprised of just 3 peptides, distinguished individual tumor entities with AUROC ≥0.90. Novel biomarkers were identified among the top classifiers, including TFF3 and CACNA2D2, and characterized using single-cell RNA sequencing data. Survival analyses validated previously implicated prognostic signatures, including blood brain barrier disruption. Conclusions: Reliable classification of intra-axial malignancies using ultra-low CSF volumes is feasible, which has ramifications for longitudinal tumor surveillance. Novel biomarkers identified here necessitate future validation. Based on emerging evidence, upfront implantation of CSF reservoirs in brain tumor patients warrants consideration." @default.
- W4286299193 created "2022-07-21" @default.
- W4286299193 creator A5010396139 @default.
- W4286299193 creator A5014870050 @default.
- W4286299193 creator A5041682013 @default.
- W4286299193 creator A5052388889 @default.
- W4286299193 creator A5055524839 @default.
- W4286299193 creator A5070567202 @default.
- W4286299193 creator A5072584423 @default.
- W4286299193 creator A5086112491 @default.
- W4286299193 date "2022-06-01" @default.
- W4286299193 modified "2023-10-08" @default.
- W4286299193 title "CSF proteomics for differentiation of brain malignancies." @default.
- W4286299193 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.2021" @default.
- W4286299193 hasPublicationYear "2022" @default.
- W4286299193 type Work @default.
- W4286299193 citedByCount "0" @default.
- W4286299193 crossrefType "journal-article" @default.
- W4286299193 hasAuthorship W4286299193A5010396139 @default.
- W4286299193 hasAuthorship W4286299193A5014870050 @default.
- W4286299193 hasAuthorship W4286299193A5041682013 @default.
- W4286299193 hasAuthorship W4286299193A5052388889 @default.
- W4286299193 hasAuthorship W4286299193A5055524839 @default.
- W4286299193 hasAuthorship W4286299193A5070567202 @default.
- W4286299193 hasAuthorship W4286299193A5072584423 @default.
- W4286299193 hasAuthorship W4286299193A5086112491 @default.
- W4286299193 hasConcept C104317684 @default.
- W4286299193 hasConcept C121608353 @default.
- W4286299193 hasConcept C126322002 @default.
- W4286299193 hasConcept C142724271 @default.
- W4286299193 hasConcept C143998085 @default.
- W4286299193 hasConcept C2775934546 @default.
- W4286299193 hasConcept C2776429142 @default.
- W4286299193 hasConcept C2779130545 @default.
- W4286299193 hasConcept C2779399171 @default.
- W4286299193 hasConcept C2779529041 @default.
- W4286299193 hasConcept C2779651940 @default.
- W4286299193 hasConcept C46111723 @default.
- W4286299193 hasConcept C55493867 @default.
- W4286299193 hasConcept C71924100 @default.
- W4286299193 hasConcept C86803240 @default.
- W4286299193 hasConceptScore W4286299193C104317684 @default.
- W4286299193 hasConceptScore W4286299193C121608353 @default.
- W4286299193 hasConceptScore W4286299193C126322002 @default.
- W4286299193 hasConceptScore W4286299193C142724271 @default.
- W4286299193 hasConceptScore W4286299193C143998085 @default.
- W4286299193 hasConceptScore W4286299193C2775934546 @default.
- W4286299193 hasConceptScore W4286299193C2776429142 @default.
- W4286299193 hasConceptScore W4286299193C2779130545 @default.
- W4286299193 hasConceptScore W4286299193C2779399171 @default.
- W4286299193 hasConceptScore W4286299193C2779529041 @default.
- W4286299193 hasConceptScore W4286299193C2779651940 @default.
- W4286299193 hasConceptScore W4286299193C46111723 @default.
- W4286299193 hasConceptScore W4286299193C55493867 @default.
- W4286299193 hasConceptScore W4286299193C71924100 @default.
- W4286299193 hasConceptScore W4286299193C86803240 @default.
- W4286299193 hasIssue "16_suppl" @default.
- W4286299193 hasLocation W42862991931 @default.
- W4286299193 hasOpenAccess W4286299193 @default.
- W4286299193 hasPrimaryLocation W42862991931 @default.
- W4286299193 hasRelatedWork W3002552315 @default.
- W4286299193 hasRelatedWork W3021668765 @default.
- W4286299193 hasRelatedWork W3121078316 @default.
- W4286299193 hasRelatedWork W3121975692 @default.
- W4286299193 hasRelatedWork W4200579612 @default.
- W4286299193 hasRelatedWork W4205786381 @default.
- W4286299193 hasRelatedWork W4282038394 @default.
- W4286299193 hasRelatedWork W4308917339 @default.
- W4286299193 hasRelatedWork W4313644488 @default.
- W4286299193 hasRelatedWork W3107561318 @default.
- W4286299193 hasVolume "40" @default.
- W4286299193 isParatext "false" @default.
- W4286299193 isRetracted "false" @default.
- W4286299193 workType "article" @default.